AI assistant
Aker BioMarine — M&A Activity 2010
Nov 17, 2010
3527_rns_2010-11-17_ea2fd53f-051d-48ec-a570-f0417b0d57bd.html
M&A Activity
Open in viewerOpens in your device viewer
AKBM - Completion of the sale of 50% of the shares in Trygg Pharma Holding AS to Lindsay Goldberg and the acquisition of EPAX Holding AS from Austevoll Seafood ASA
Reference is made to the stock exchange notice of 3 September 2010 regarding
Lindsay Goldberg's acquisition of 50 % of the shares in a newly established
joint venture company, Trygg Pharma Holding AS, from Aker BioMarine ASA, the
stock exchange notice of 3 September 2010 regarding the purchase by Trygg Pharma
AS (a wholly owned subsidiary of Trygg Pharma Holding AS) of 100% of the shares
in Epax Holding AS from Austevoll Seafood ASA, and the prospectus dated 29
September 2010 prepared in connection with the rights issue completed in Aker
BioMarine ASA.
Lindsay Goldberg's acquisition of 50% of the shares in Trygg Pharma Holding AS
from Aker BioMarine ASA and the acquisition by Trygg Pharma AS of 100% of the
shares in Epax Holding AS from Austevoll Seafood ASA have been completed in
accordance with the agreements entered into between the parties, as further
described in the abovementioned stock exchange notices and the prospectus.
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1463350]